Notice NOT-AG-24-098 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-25-356 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to enhance the participation of individuals from nationally underrepresented backgrounds to enhance the participation of individuals from nationally underrepresented backgrounds in cardiovascular, pulmonary, hematologic and sleep disorders research across the career development continuum by providing support to institutions that promote diversity. The NHLBI's T32 Training Program for Institutions That Promote Diversity is a Ruth L. Kirschstein National Research Service Award Program intended to support training of predoctoral and health professional students and individuals in postdoctoral training institutions with an institutional mission focused on serving health disparity populations not well represented in scientific research, or institutions that have been identified by federal legislation as having an institutional mission focused on these populations, with the potential to develop meritorious training programs in cardiovascular, pulmonary, and hematologic diseases, and sleep disorders. These institutions are uniquely positioned to engage minority and other health disparity populations in research, translation, and implementation of research advances that impact health outcomes, as well as provide health care for these populations. This NOFO does not allow appointed trainees to lead an independent clinical trial but does allow them to obtain research experience in a clinical trial led by a mentor or co-mentor.

Funding Opportunity PAR-25-353 from the NIH Guide for Grants and Contracts. Reissue of PAR-20-119. This FOA encourages applications to advance the discovery, preclinical development, and proof of concept (PoC) testing of new, rationally based candidate agents and neurostimulation approaches to treat mental disorders, substance use disorders (SUDs) or alcohol use disorder (AUD), and to develop novel ligands and circuit-engagement devices as tools to further characterize existing or to validate new drug/device targets. Partnerships between academia and industry are strongly encouraged. This FOA supports a research program of multiple projects directed toward a specific major objective, basic theme or program goal, requiring a broadly based, multidisciplinary and often long-term approach. Projects seeking support for a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies should consider the companion U01 FOA.

Funding Opportunity PAR-25-352 from the NIH Guide for Grants and Contracts. Reissue of PAR-20-118. This Notice of Funding Opportunity (NOFO) encourages applications to advance the discovery, preclinical development, and proof of concept (PoC) testing of new, rationally based candidate agents and neurostimulation approaches to treat mental disorders, substance use disorders (SUDs) or alcohol use disorder (AUD), and to develop novel ligands and circuit-engagement devices as tools to further characterize existing or to validate new drug/device targets. Partnerships between academia and industry are strongly encouraged. This NOFO using the U01 mechanism supports a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies Projects seeking support for a research program of multiple projects directed toward a specific major objective, basic theme or program goal, requiring a broadly based, multidisciplinary and often long-term approach should consider the companion U19 FOA.

Notice NOT-RM-25-001 from the NIH Guide for Grants and Contracts

Notice NOT-AG-24-031 from the NIH Guide for Grants and Contracts

Notice NOT-CA-25-021 from the NIH Guide for Grants and Contracts

Notice NOT-HL-25-004 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DK-26-007 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications for studies of type 1 diabetes etiology and pathogenesis using data and samples from clinical trials and studies. This opportunity is intended to fund investigative teams collaborating to answer important questions about disease mechanisms leading to improved prevention of type 1 diabetes.

Competitive: Hull University Teaching Hospitals NHS Trust: Job summary RADIOTHERAPY PHYSICS, MEDICAL PHYSICS AND CLINICAL ENGINEERING DIVISION Band 8A (subject to Job Evaluation) Principal Clinical Scientis Cottingham, United Kingdom

Notice NOT-OD-25-063 from the NIH Guide for Grants and Contracts

Competitive: CK Group: CK Group are working in partnership with Nxera Pharma to recruit a Senior Scientist/Lead Scientist - Computational Chemistry, to join their Computational Chemistry team. Applications are... Cambridge

Competitive: CK Group: CK Group are working in partnership with Nxera Pharma to recruit a Senior Scientist/Lead Scientist - Computational Chemistry, to join their Computational Chemistry team. Applications are... Cambridge

Notice NOT-HL-24-032 from the NIH Guide for Grants and Contracts

Notice NOT-NS-25-009 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-25-313 from the NIH Guide for Grants and Contracts. The purpose of the NCI Pathway to Independence Award (K99/R00) program is to facilitate a timely transition of talented postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide independent NCI research support during this transition in order to help awardees to launch competitive, independent research careers.

Notice NOT-CA-25-022 from the NIH Guide for Grants and Contracts

Notice NOT-OD-25-064 from the NIH Guide for Grants and Contracts

Competitive: Illumina, Inc.: What if the work you did every day could impact the lives of people you know? Or all of humanity? At Illumina, we are expanding access to genomic tec Cambridge, United Kingdom

Competitive: Georg-August-Universität Göttingen: At the University of Göttingen -Public Law Foundation-, Abt. Forstgenetik und Forstpflanzenzüchtung, there is a position as Research Scientist (Postdo Göttingen, Germany